We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Diabetes Care at Austrian GPs (DCA09)

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00979394
First Posted: September 18, 2009
Last Update Posted: August 17, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Bristol-Myers Squibb
Information provided by:
AstraZeneca
  Purpose

This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:

  • To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,
  • To evaluate representative profile of patient with T2D in Austria,
  • To evaluate which medical therapies are used.

Condition
Type 2 Diabetes

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diabetes Care Austria 2009

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Evaluate characteristics or co morbidities being existent for patient with T2D at GP [ Time Frame: Once per patient ]

Enrollment: 1513
Study Start Date: October 2009
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Patients with type 2 diabetes

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
GPs
Criteria

Inclusion Criteria:

  • Diabetes mellitus type II

Exclusion Criteria:

  • Diabetes mellitus type I
  • Gestation diabetes
  • Induced diabetes
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00979394


Sponsors and Collaborators
AstraZeneca
Bristol-Myers Squibb
Investigators
Study Chair: Bernhard Ludvig General Hospital Vienna
Study Chair: Guntram Schernthaner Krankenanstalt Rudolfsstiftung
  More Information

Responsible Party: MC MD, AstraZeneca
ClinicalTrials.gov Identifier: NCT00979394     History of Changes
Other Study ID Numbers: NIS-CAT-DUM-2009/1
First Submitted: September 17, 2009
First Posted: September 18, 2009
Last Update Posted: August 17, 2010
Last Verified: August 2010

Keywords provided by AstraZeneca:
Diabetes Care at GPs in Austria
Characteristic of diabetes patients at GPs in Austria

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases


To Top